Castle Biosciences to Acquire AltheaDx


Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are focused on mental health.

Read More

Next Post

4 Areas That Require Extensive IT Monitoring Amid Digitalization in Healthcare

The digitalization of healthcare has increased the demand for IT systems monitoring and made it a mission-critical undertaking for health systems’ IT departments. Brian St. Jean, presales system engineer at Paessler, a monitoring software company, says IT systems monitoring should occur in four areas: digital medical devices, the health system’s […]